Literature DB >> 2427928

Members of the src and ras oncogene families supplant the epidermal growth factor requirement of BALB/MK-2 keratinocytes and induce distinct alterations in their terminal differentiation program.

B Weissman, S A Aaronson.   

Abstract

BALB-/MK-2 mouse epidermal keratinocytes required epidermal growth factor for proliferation and terminally differentiated in response to high Ca2+ concentration. Infection with retroviruses containing transforming genes of the src and ras oncogene families led to rapid loss of epidermal growth factor dependence, in some cases, accompanied by alterations in cellular morphology. The virus-altered cells continued to proliferate in the presence of high levels of extracellular calcium but exhibited alterations in normal keratinocyte terminal differentiation that appear to be specific to the particular oncogene. These alterations bore similarities to abnormalities in differentiation observed in naturally occurring squamous epithelial malignancies.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2427928      PMCID: PMC369167          DOI: 10.1128/mcb.5.12.3386-3396.1985

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  35 in total

1.  Quantitative assay for carcinogen altered differentiation in mouse epidermal cells.

Authors:  M F Kulesz-Martin; B Koehler; H Hennings; S H Yuspa
Journal:  Carcinogenesis       Date:  1980       Impact factor: 4.944

2.  Development of 3T3-like lines from Balb-c mouse embryo cultures: transformation susceptibility to SV40.

Authors:  S A Aaronson; G J Todaro
Journal:  J Cell Physiol       Date:  1968-10       Impact factor: 6.384

Review 3.  The immunopathology of pemphigus and bullous pemphigoid.

Authors:  E H Beutner; R E Jordon; T P Chorzelski
Journal:  J Invest Dermatol       Date:  1968-08       Impact factor: 8.551

Review 4.  Oncogenes and proto-oncogenes: how do they differ?

Authors:  T Hunter
Journal:  J Natl Cancer Inst       Date:  1984-10       Impact factor: 13.506

Review 5.  Regulation of cell growth and transformation by tyrosine-specific protein kinases: the search for important cellular substrate proteins.

Authors:  J A Cooper; T Hunter
Journal:  Curr Top Microbiol Immunol       Date:  1983       Impact factor: 4.291

6.  The transforming protein of Moloney murine sarcoma virus is a soluble cytoplasmic protein.

Authors:  J Papkoff; E A Nigg; T Hunter
Journal:  Cell       Date:  1983-05       Impact factor: 41.582

7.  Differentiation of F9 teratocarcinoma stem cells after transfer of c-fos proto-oncogenes.

Authors:  R Müller; E F Wagner
Journal:  Nature       Date:  1984 Oct 4-10       Impact factor: 49.962

8.  Keratinocytes blocked in phorbol ester-responsive early stage of terminal differentiation by sarcoma viruses.

Authors:  S H Yuspa; A E Kilkenny; J Stanley; U Lichti
Journal:  Nature       Date:  1985 Apr 4-10       Impact factor: 49.962

9.  Altered growth and differentiation of cultured mouse epidermal cells infected with oncogenic retrovirus: contrasting effects of viruses and chemicals.

Authors:  S H Yuspa; W Vass; E Scolnick
Journal:  Cancer Res       Date:  1983-12       Impact factor: 12.701

10.  Specific epidermal protein markers are modulated during calcium-induced terminal differentiation.

Authors:  J R Stanley; S H Yuspa
Journal:  J Cell Biol       Date:  1983-06       Impact factor: 10.539

View more
  17 in total

1.  Specific changes of Ras GTPase-activating protein (GAP) and a GAP-associated p62 protein during calcium-induced keratinocyte differentiation.

Authors:  E Filvaroff; E Calautti; F McCormick; G P Dotto
Journal:  Mol Cell Biol       Date:  1992-12       Impact factor: 4.272

2.  Expression of H-ras correlates with metastatic potential: evidence for direct regulation of the metastatic phenotype in 10T1/2 and NIH 3T3 cells.

Authors:  S E Egan; G A McClarty; L Jarolim; J A Wright; I Spiro; G Hager; A H Greenberg
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

3.  Selective inhibition of growth-related gene expression in murine keratinocytes by transforming growth factor beta.

Authors:  R J Coffey; C C Bascom; N J Sipes; R Graves-Deal; B E Weissman; H L Moses
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

4.  Coding sequence and growth regulation of the human vimentin gene.

Authors:  S Ferrari; R Battini; L Kaczmarek; S Rittling; B Calabretta; J K de Riel; V Philiponis; J F Wei; R Baserga
Journal:  Mol Cell Biol       Date:  1986-11       Impact factor: 4.272

5.  Role of a tumor-suppressor gene in the negative control of anchorage-independent growth of Syrian hamster cells.

Authors:  M Koi; C A Afshari; L A Annab; J C Barrett
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

6.  Tyrosine phosphorylation is an early and specific event involved in primary keratinocyte differentiation.

Authors:  E Filvaroff; D F Stern; G P Dotto
Journal:  Mol Cell Biol       Date:  1990-03       Impact factor: 4.272

7.  Neoplastic transformation of mouse mammary epithelial cells by deregulated myc expression.

Authors:  N T Telang; M P Osborne; L A Sweterlitsch; R Narayanan
Journal:  Cell Regul       Date:  1990-10

8.  Transgenic overexpression of transforming growth factor alpha bypasses the need for c-Ha-ras mutations in mouse skin tumorigenesis.

Authors:  R Vassar; M E Hutton; E Fuchs
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

9.  Phospholipase C-mediated hydrolysis of phosphatidylcholine is a target of transforming growth factor beta 1 inhibitory signals.

Authors:  M T Diaz-Meco; I Dominguez; L Sanz; M M Municio; E Berra; M E Cornet; A Garcia de Herreros; T Johansen; J Moscat
Journal:  Mol Cell Biol       Date:  1992-01       Impact factor: 4.272

10.  The calcium signal for BALB/MK keratinocyte terminal differentiation counteracts epidermal growth factor (EGF) very early in the EGF-induced proliferative pathway.

Authors:  P P Di Fiore; J Falco; I Borrello; B Weissman; S A Aaronson
Journal:  Mol Cell Biol       Date:  1988-02       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.